Glenmark Specialty S.a.

Glenmark Pharmaceuticals S.a.

Dinesh Pradeep Wale

Neelima Khairatkar-Joshi

Vikram Mansingh Bhosale

Abhay Kulkarni

Patrick Keohane

Sudeesh K Tantry

Piyush Agarwal

Chad Oh

Ulhas R Dhuppad

Chandrakant Dhatrak

Rajesh Ankam

Ashok Katkurwar

Yashwant Gupta

Abraham Thomas

Vidya Ganapati Kattige

Sukeerthi Kumar

Sachin Sundarlal Chaudhari

Indranil Mukhopadhyay

A nasal dispensing device and pharmaceutical composition includes a container; a dispenser head having at least a pump, a dispensing channel, and a dispensing orifice; a dip tube; and a pharmaceutical composition comprising mometasone, an ester thereof (e.g., mometasone furoate), or a salt thereof and olopatadine or its salt (e.g., olopatadine hydrochloride). The container can have a conically shaped internal bottom, angled downwardly toward a center, and a further angularly deepened well, centrally located, with the dip tube extending into the well. An optional cap is provided that includes a sealing sleeve communicating in a seal tight manner with a perimeter of a lateral wall of the dispenser head.

Dispensing device and pharmaceutical composition for the treatment of rhinitis

The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.

Treatment of allergic rhinitis using a combination of mometasone and olopatadine

The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a human) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.

The present patent application relates to a method of treating allergic rhinitis in a subject (preferably a human) by administering a combination of mometasone or its salt and olopatadine or its salt.

The present patent application relates to treatment of a respiratory disorder using TRPA1 antagonists. Particularly, the present patent application relates to treatment of a respiratory disorder using a TRPA1 antagonist, wherein the TRPA1 antagonist is administered by inhalation route to a subject in need thereof.

Treatment of respiratory disorders using TRPA1 antagonists

Growing community of inventors

Maharashtra, India

Dinesh Pradeep Wale